HCA Healthcare (NYSE:HCA) Price Target Raised to $496.00

HCA Healthcare (NYSE:HCA) had its price objective boosted by Royal Bank Of Canada from $435.00 to $496.00 in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. The brokerage currently has an outperform rating on the stock.

A number of other analysts have also commented on the company. Oppenheimer decreased their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a research note on Monday, July 27th. Wells Fargo & Company increased their price target on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Finally, Morgan Stanley lowered their target price on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $466.35.

HCA Healthcare Stock Up 1.3%

HCA opened at $450.72 on Wednesday. The stock has a market cap of $97.58 billion, a PE ratio of 15.09, a price-to-earnings-growth ratio of 1.50 and a beta of 1.10. HCA Healthcare has a twelve month low of $353.99 and a twelve month high of $556.52. The company has a fifty day moving average of $420.82 and a 200-day moving average of $419.97.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the prior year, the firm posted $6.84 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. Sell-side analysts anticipate that HCA Healthcare will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.

Institutional Investors Weigh In On HCA Healthcare

Large investors have recently added to or reduced their stakes in the business. MidFirst Bank purchased a new position in shares of HCA Healthcare in the 2nd quarter worth about $28,000. Clearstead Trust LLC purchased a new stake in HCA Healthcare in the second quarter worth approximately $29,000. Cedar Mountain Advisors LLC purchased a new position in shares of HCA Healthcare during the first quarter worth approximately $33,000. Delos Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the 2nd quarter valued at $35,000. Finally, Merkkuri Wealth Advisors LLC purchased a new position in HCA Healthcare in the 1st quarter worth $43,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.